$121.04 2.1%
RVTY Stock Price vs. AI Score
Data gathered: November 1

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Revvity

PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families.


Revvity
Price $121.04
Target Price Sign up
Volume 1,450,000
Market Cap $14.8B
Year Range $99.26 - $127.68
Dividend Yield 0.23%
PE Ratio 75.02
Analyst Rating 50% buy
Earnings Date November 4 '24
Industry Health Care Services

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q2 '24692M648M43M55M185M1.220
Q1 '24650M647M3.7M26M147M0.980
Q4 '23767M-456M1.22B79M167M1.250
Q3 '23645M639M5.9M9.5M144M1.180
Q2 '23683M667M17M36M167M1.210

Insider Transactions View All

Vohra Tajinder S filed to sell 19,652 shares at $122.6.
October 10 '24
Vohra Tajinder S filed to sell 19,672 shares at $121.7.
October 10 '24
Vohra Tajinder S filed to sell 21,806 shares at $123.
October 9 '24
Vohra Tajinder S filed to sell 22,299 shares at $122.5.
October 9 '24
Vohra Tajinder S filed to sell 23,960 shares at $123.1.
October 9 '24

Congress Trading View All

Politician Filing Date Type Size
Rohit Khanna
Democrat
May 6, 24 Buy $1K - $15K
Rohit Khanna
Democrat
Nov 8, 23 Buy $1K - $15K
Rohit Khanna
Democrat
Nov 8, 23 Buy $1K - $15K

What is the Market Cap of Revvity?

The Market Cap of Revvity is $14.8B.

What is Revvity's PE Ratio?

As of today, Revvity's PE (Price to Earnings) ratio is 75.02.

When does Revvity report earnings?

Revvity will report its next earnings on November 4 '24.

What is the current stock price of Revvity?

Currently, the price of one share of Revvity stock is $121.04.

How can I analyze the RVTY stock price chart for investment decisions?

The RVTY stock price chart above provides a comprehensive visual representation of Revvity's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Revvity shares. Our platform offers an up-to-date RVTY stock price chart, along with technical data analysis and alternative data insights.

Does RVTY offer dividends to its shareholders?

Yes, Revvity (RVTY) offers dividends to its shareholders, with a dividend yield of 0.23%. This dividend yield represents Revvity's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Revvity in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Revvity?

Some of the similar stocks of Revvity are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.